We are live on ! Find out more
RNAC icon

Cartesian Therapeutics
RNAC

61 hedge funds and large institutions have $136M invested in Cartesian Therapeutics in 2020 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,900% more call options, than puts

Call options by funds: $70K | Put options by funds: $1K

400% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 6

183% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 6

61% more funds holding

Funds holding: 38 → 61 (+23)

43% more capital invested

Capital invested by funds: $95M → $136M (+$41.2M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.6% less ownership

Funds ownership: 2.78% → 2.18% (-0.6%)

Holders
61
Holders Change
+23
Holders Change %
+60.53%
% of All Funds
1.34%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
30
Increased
17
Reduced
6
Closed
6
Calls
$70K
Puts
$1K
Net Calls
+$69K
Net Calls Change
+$69K

Top Buyers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
+$25.3M
2
Citadel Advisors
Citadel Advisors
Florida
+$5.46M
3
Millennium Management
Millennium Management
New York
+$3.8M
4
LGM
Logos Global Management
California
+$3.58M
5
RCM
RA Capital Management
Massachusetts
+$2.8M

Top Sellers

Rank Fund Capital Flow
1
WA
Wasatch Advisors
Utah
-$3.84M
2
Man Group
Man Group
United Kingdom
-$2.65M
3
SRF
Silver Rock Financial
California
-$1.09M
4
O
OrbiMed
New York
-$918K
5
BFM
Boothbay Fund Management
New York
-$395K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
51
Charles Schwab
California
$36K – – –
Walleye Trading
52
Walleye Trading
New York
$27K +$35.4K +367 New
Stifel Financial
53
Stifel Financial
Missouri
$26K -$19.3K -200 -36%
Victory Capital Management
54
Victory Capital Management
Texas
$26K +$35.6K +369 New
Macquarie Group
55
Macquarie Group
Australia
$24K +$31.8K +329 New
CLOS
56
Compagnie Lombard Odier SCmA
Switzerland
$23K – – –
CSS
57
Cubist Systematic Strategies
Connecticut
$4K +$5.89K +61 New
TWA
58
TCI Wealth Advisors
Arizona
$1K +$965 +10 New
BNP Paribas Financial Markets
59
BNP Paribas Financial Markets
France
$87 – – –
SRF
60
Silver Rock Financial
California
– -$1.09M -15,262 Closed
BFM
61
Boothbay Fund Management
New York
– -$395K -5,528 Closed
T. Rowe Price Associates
62
T. Rowe Price Associates
Maryland
– -$194K -2,713 Closed
SSA
63
Schonfeld Strategic Advisors
New York
– -$43K -607 Closed
TRCT
64
Tower Research Capital (TRC)
New York
– -$29K -405 Closed
Deutsche Bank
65
Deutsche Bank
Germany
– -$15K -215 Closed
Simplex Trading
66
Simplex Trading
Illinois
– +$290 +3 New
Wells Fargo
67
Wells Fargo
California
– +$579 +6 New
1 2
3

RNAC Hedge Fund Activity: Q1 2020 in Review

61 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Cartesian Therapeutics (RNAC) for Q1 2020, worth a combined $136M — up 43% from $95M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new RNAC positions and 6 closed out — a net gain of 24 holders — while 17 added to existing stakes and 6 trimmed.

The largest buyer was Vivo Capital, opening a new position worth an estimated $25.3M. The largest seller was Wasatch Advisors, cutting an estimated $3.84M.

  • 61 institutional investors held Cartesian Therapeutics (RNAC) as of Q1 2020, up from 38 in Q4 2019.
  • Funds reported $136M of Cartesian Therapeutics stock for Q1 2020, up 43% quarter-over-quarter.
  • 30 funds opened new Cartesian Therapeutics positions in Q1 2020 and 6 closed out, a net change of +24 holders.
  • The largest Cartesian Therapeutics buyer in Q1 2020 was Vivo Capital, an estimated $25.3M added.
  • The largest Cartesian Therapeutics seller in Q1 2020 was Wasatch Advisors, an estimated $3.84M sold.

Based on aggregated 13F filings for Q1 2020.